Skip to main content
. Author manuscript; available in PMC: 2019 Jan 1.
Published in final edited form as: Clin Cancer Res. 2017 Oct 23;24(1):62–72. doi: 10.1158/1078-0432.CCR-17-0357

Table 2.

Treatment-Related Adverse Events Occurring in at Least 20% of Patients

Event (n=14)
# of patients (%)
Injection site reaction 11 (79)
Rash acneiform 11 (79)
Flu-like symptoms 5 (36)
Fatigue 3 (21)
Diarrhea 3 (21)
Malaise 2 (14)
Fever 2 (14)
Infusion reaction 2 (14)
Headache 2 (14)